Hepatitis B Annual

REVIEW ARTICLE
Year
: 2007  |  Volume : 4  |  Issue : 1  |  Page : 107--117

Management of severe acute hepatitis B


Sudeep Khanna, Rakesh Tandon 
 Department of Gastroenterology and Metabolic Disorders, Pushpawati Singhania Research Institute for Liver, Renal and Digestive Diseases, Sheikh Sarai, Phase II, Press Enclave Road, New Delhi-110 017, India

Correspondence Address:
Sudeep Khanna
Department of Gastroenterology and Metabolic Disorders, Pushpawati Singhania Research Institute for Liver, Renal and Digestive Diseases, Sheikh Sarai, Phase II, Press Enclave Road, New Delhi-110 017
India

HBV infection is a major public health problem. Acute viral hepatitis B is successfully cleared in more than 95% of immunocompetent patients. HBV infection can cause severe acute hepatitis which can progress to acute liver failure. The purpose of this review is to discuss the immune response in acute hepatitis B and the possible role of HBV genotypes in development of severe acute HBV related hepatitis, define severe acute hepatitis B and to look at the role of the available antivirals in this clinical setting.


How to cite this article:
Khanna S, Tandon R. Management of severe acute hepatitis B.Hep B Annual 2007;4:107-117


How to cite this URL:
Khanna S, Tandon R. Management of severe acute hepatitis B. Hep B Annual [serial online] 2007 [cited 2019 Aug 17 ];4:107-117
Available from: http://www.hepatitisbannual.org/article.asp?issn=0972-9747;year=2007;volume=4;issue=1;spage=107;epage=117;aulast=Khanna;type=0